Profile
Yuji Matsumoto currently works at ILS, Inc., as Director and Nomura Securities Co., Ltd., as Research Analyst.
Yuji Matsumoto active positions
Companies | Position | Start |
---|---|---|
Nomura Securities Co., Ltd.
Nomura Securities Co., Ltd. Investment Banks/BrokersFinance Nomura Securities Co., Ltd. (NSC) is a wholly-owned brokerage subsidiary of Nomura Holdings, Inc. (TSE: 8604; NYSE: NMR). Headquartered in Tokyo, the firm was founded in 1925. NSC places a strong emphasis on research, both fundamental and quantitative. In addition to stock and bond underwriting, their activities include IPO and M&A advisory, wealth management, separately managed accounts, fund wrap services, prime brokerage and structured equity finance. Their clients include institutions, hedge funds, private banks and private equity funds as well as corporate clients and retail investors. | Analyst-Equity | - |
ILS, Inc.
ILS, Inc. Chemicals: Major DiversifiedProcess Industries ILS, Inc. engages in the development, manufacture and sales of pharmaceutical products by using the technology of peptide synthesis and the extraction and purification of biogenic substances. It also offers functional food ingredients. The company was founded on May 20, 2003 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Nomura Securities Co., Ltd.
Nomura Securities Co., Ltd. Investment Banks/BrokersFinance Nomura Securities Co., Ltd. (NSC) is a wholly-owned brokerage subsidiary of Nomura Holdings, Inc. (TSE: 8604; NYSE: NMR). Headquartered in Tokyo, the firm was founded in 1925. NSC places a strong emphasis on research, both fundamental and quantitative. In addition to stock and bond underwriting, their activities include IPO and M&A advisory, wealth management, separately managed accounts, fund wrap services, prime brokerage and structured equity finance. Their clients include institutions, hedge funds, private banks and private equity funds as well as corporate clients and retail investors. | Finance |
ILS, Inc.
ILS, Inc. Chemicals: Major DiversifiedProcess Industries ILS, Inc. engages in the development, manufacture and sales of pharmaceutical products by using the technology of peptide synthesis and the extraction and purification of biogenic substances. It also offers functional food ingredients. The company was founded on May 20, 2003 and is headquartered in Tokyo, Japan. | Process Industries |
- Stock Market
- Insiders
- Yuji Matsumoto